Navigation Links
Idenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Date:4/24/2008

CAMBRIDGE, Mass., April 24 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the upcoming Morgan Stanley Global Healthcare Unplugged Conference on Wednesday, April 30, 2008 at 3:00 p.m. ET at The Ritz Carlton in Key Biscayne, Florida.

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com. Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replays will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals Contact:

Teri Dahlman (617) 995-9905


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
2. Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results
3. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
4. Idenix to Host Conference Call Discussing Fourth Quarter 2007 Financial Results
5. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker...s available in its catalogue: ,, Carbondioxide...http://www.reportlinker.com/p0164368/Carbondioxide..., Incubators are the most critical equipment us...d other applications for providing a controlled en...
(Date:12/2/2009)..., CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Onco...) (TSX:ONC; NASDAQ: ONCY ) announced today that in...ering, the underwriters have exercised in full the...al 637,500 units. Each unit is comprised of one co...ant, and was sold at a price of US$3.00 per unit. ...
(Date:12/2/2009)..., SINGAPORE, Dec. 2 S*BIO Pte Lt...oral JAK2 inhibitor, SB1518, at The American Socie...n in New Orleans. ,, Data will be presented on ...ion trial of SB1518 detailing its safety, tolerabi...rofile in dose levels ranging from 100 to 600 mg. ...
(Date:12/2/2009)... The Scientist, a leading scientific ma...rics’ Evolve “Intelligent” EMCCD...o;Top 10 Innovations of 2009. , ...ade; EMCCD camera from Photometrics ®, a des... EMCCD cameras for the life sciences, was ranked f...
Breaking Biology Technology:Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3
...al issues going on right now, it could be helpful ...s in yesterday,s critical moments. , ,There are m...esponsibilities. They are worth applying to your p...ferent perspectives may help broaden your view of ...onomy. Understanding the world and its global conf...
... not become us." , ,- Dread Pirate Roberts, The P...eem like a big challenge to marketers. They can be...he right opportunity, however, small business owne...ll business owners present a desirable and growing...onal Federation of Independent Business (NFIB), t...
...continues at Merge Technologies, Inc. , ,The emb...oes business as Merge Healthcare, has announced th...l" to Brian E. Pedlar, its interim co-president an...a Software , of Pedlar,s departure as of the close...ecutive to leave the company this year amid its co...
Other Biology Technology:Business leaders can learn from historical insights 2Business leaders can learn from historical insights 3Business leaders can learn from historical insights 4Business leaders can learn from historical insights 5Big opportunities with small businesses 2Big opportunities with small businesses 3Pedlar the latest executive to leave Merge 2
(Date:12/3/2009)...es to investment in energy efficient technologies ...search Council (EPSRC) Chief Executive Dave Delpy ...neering research has already brought us fuel cells... investment is needed to develop the capabilities ...n emission targets by 2020 and limit the impact of...
(Date:12/2/2009)...o secondhand cigarette smoke have an increased ris...they never smoked. , Results of this study are ...evention , a journal of the American Association f...ocus in the December issue. , This year alone, ... lung cancer; more than 159,000 will die from it a...
(Date:12/2/2009)...and alcohol consumption before head and neck cance... risk of death, according to published studies. No...ong those who continued these habits after cancer ...d to quit smoking; despite this, many still smoke....after their cancer diagnosis, increasing their ris...
Breaking Biology News(10 mins):Research is vital to a cleaner, greener, low carbon future 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Health care is only part of the puzzle 3A Social scientists analyze societys health and success 59662 1Health care is only part of the puzzle 3A Social scientists analyze societys health and success 59662 2Health care is only part of the puzzle 3A Social scientists analyze societys health and success 59662 3Fish vision discovery makes waves in natural selection 10401 1Fish vision discovery makes waves in natural selection 10401 2Fish vision discovery makes waves in natural selection 10401 3Scientists Provide First Map of Complete Human Epigenome 59653 1Scientists Provide First Map of Complete Human Epigenome 59653 2
...e high biodiversity in tropical forests has both f...f a century. In the hopes of finding an answer to ...n to the spatial patterns of such communities and ...r than a pencil in plots covering 25 to 52ha of tr...ed in The American Naturalist a German - Sri Lanka...
...g a novel deep sequencing technology that can in o...ting well over a billion bases of DNA, a research ...orking to unmask where, why and how certain genes ...e world,s food supply. , The goal of the four-yea...ant from the National Science Foundation (NSF), is...
...t caused the extinction of mammoths and the declin...ns hotly debated. Overhunting by Paleoindians, cli...causes. But an idea once considered a little out t...international researchers, including two Northern ...at a comet or low-density object barreling toward ...
Other Biology News:UD leads $5.3-million research project on rice epigenetics 2UD leads $5.3-million research project on rice epigenetics 3UD leads $5.3-million research project on rice epigenetics 4Research team says extraterrestrial impact to blame for Ice Age extinctions 2Research team says extraterrestrial impact to blame for Ice Age extinctions 3
Boekel Rocker II 115VAC from Boekel Scientific
Rat Complement Lyophilized Powder from Equitech-Bio
High-Binding EIA 96 Well Strip Plates from Cayman Chemical
Zymoclean Gel DNA Recovery Kit from Zymo Research
Biology Products: